Category: News Summary
-
Cannabis corner: Chemesis (CSI.C) signs $6M deal, Khiron (KHRN.V) eyes greater EU-LatAm trade and iAnthus (IAN.C) deepens Florida roots
Chemesis International (CSI.C) subsidiary, Natural Ventures, has signed a three year, USD$6M minimum purchase agreement with PR ONE, a medical cannabis company based in Puerto Rico. Over the deal’s three-year lifespan, PR ONE has signed on to purchase a minimum of $300,000 of cannabis infused products and a minimum of $200,000 of flower monthly from Chemesis’…
-
Biome Grow (BIO.C) Q1 financials shows benefits of even-handed management and sustainable growth
Biome Grow (BIO.C) has just released its Q1 financials and confirmed what we already knew about management: it’s preference of responsible growth at a defensible rate. The quick ratio is a good metric to apply to developing small-cap companies like Biome Grow. It measures a company’s short-term liquidity and gauges their ability to meet its…
